Obsessive Compulsive Disorder Mental and Behavioural Disorders Obsessive-compulsive disorder
Conditions
Interventions
Participants will be randomly allocated to one of two treatments. Both treatments will be delivered by trained CBT and EMDR therapists.
1. CBT (based on exposure and response prevention) aims to redu
Sponsors
Leeds Community Healthcare NHS Trust (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients have been referred or signposted to an Improving Access to Psychological Therapies (IAPT) service in Leeds and are suitable for treatment in a primary care setting on the basis of: 1. Having a common mental disorder 2. Low risk of harm to self or others Patients must meet ICD-10 diagnostic criteria for OCD, and this is the person's primary concern or reason for seeking treatment
Exclusion criteria
Exclusion criteria: This study is embedded in routine primary care mental health services, which specifically supports patients with common mental health problems 1. Patients with severe mental health problems are treated in psychiatric or secondary care mental health services, are routinely referred on to secondary care and therefore will not be recruited to this trial 2. Patients who are unsuitable for treatment in a primary care setting due to acute suicidal risk 3. Patients who meet criteria for alcohol or drug dependence (identified using a validated Severity of Dependence Scale) 4. Patients who do not currently meet diagnostic criteria for OCD as defined by the ICD-10 5. OCD is not the person's primary concern 6. Patients who are currently using prescribed benzodiazepines, which is a contra-indication to EMDR treatment. Potential participants using any other sedatives (e.g. opiates) will be interviewed by the study co-ordinator to determine whether the current dose may pose an obstacle to treatment (in consultation with the prescribing physician)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Self-rated Yale-Brown Obsessive Compulsive Scale (YBOCS) questionnaire Measured at the beginning of every treatment sessions and at 6 months follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Routine IAPT measures: 1. Obsessive-Compulsive Inventory (OCI) (for obsessive compulsive symptoms) 2. Patient Health Questionnaire (PHQ9) (for depressive symptoms) 3. Generalized Anxiety Disorder (GAD7) (for anxiety symptoms) 4. Work and Social Adjustment Scale (WSAS) (measure of general functioning and adjustment) | — |
Countries
United Kingdom
Outcome results
None listed